Abstract:Sickle cell disease (SCD) is the monogenic hemoglobinopathy where mutated sickle hemoglobin molecules polymerize to form long fibers under deoxygenated state and deform red blood cells (RBCs) into predominantly sickle form. Sickled RBCs stick to the vascular bed and obstruct blood flow in extreme conditions, leading to acute painful vaso-occlusion crises (VOCs) - the leading cause of mortality in SCD. Being a blood disorder of deformed RBCs, SCD manifests a wide-range of organ-specific clinical complications of life (in addition to chronic pain) such as stroke, acute chest syndrome (ACS) and pulmonary hypertension in the lung, nephropathy, auto-splenectomy, and splenomegaly, hand-foot syndrome, leg ulcer, stress erythropoiesis, osteonecrosis and osteoporosis. The physiological inception for VOC was initially thought to be only a fluid flow problem in microvascular space originated from increased viscosity due to aggregates of sickled RBCs; however, over the last three decades, multiple molecular and cellular mechanisms have been identified that aid the VOC in vivo. Activation of adhesion molecules in vascular endothelium and on RBC membranes, activated neutrophils and platelets, increased viscosity of the blood, and fluid physics driving sickled and deformed RBCs to the vascular wall (known as margination of flow) - all of these come together to orchestrate VOC. Microfluidic technology in sickle research was primarily adopted to benefit from mimicking the microvascular network to observe RBC flow under low oxygen conditions as models of VOC. However, over the last decade, microfluidics has evolved as a valuable tool to extract biophysical characteristics of sickle red cells, measure deformability of sickle red cells under simulated oxygen gradient and shear, drug testing, in vitro models of intercellular interaction on endothelialized or adhesion molecule-functionalized channels to understand adhesion in sickle microenvironment, characterizing biomechanics and microrheology, biomarker identification, and last but not least, for developing point-of-care diagnostic technologies for low resource setting. Several of these platforms have already demonstrated true potential to be translated from bench to bedside. Emerging microfluidics-based technologies for studying heterotypic cell-cell interactions, organ-on-chip application and drug dosage screening can be employed to sickle research field due to their wide-ranging advantages.

Overview of cell motility-based sickle cell disease diagnostic system in shearing digital holographic microscopy

Automated sickle cell disease identification in human red blood cells using a lensless single random phase encoding biosensor and convolutional neural networks

Integrating deep learning with microfluidics for biophysical classification of sickle red blood cells adhered to laminin

Smartphone-based Sickle Cell Disease Detection and Monitoring for Point-of-Care Settings

Automated screening of sickle cells using a smartphone-based microscope and deep learning

A framework of computer vision-enhanced microfluidic approach for automated assessment of the transient sickling kinetics in sickle red blood cells

Microfluidics in Sickle Cell Disease Research: State of the Art and a Perspective Beyond the Flow Problem

A microfluidic-informatics assay for quantitative physical occlusion measurement in sickle cell disease

Computing Sickle Erythrocyte Health Index Based on Quantitative Phase Imaging and Machine Learning

A Deep Convolutional Neural Network for Classification of Red Blood Cells in Sickle Cell Anemia.

AI-based analysis of 3D position and orientation of red blood cells using a digital in-line holographic microscopy

Optical characterization of red blood cells from individuals with sickle cell trait and disease in Tanzania using quantitative phase imaging

Feature tracking microfluidic analysis reveals differential roles of viscosity and friction in sickle cell blood

Mathematical Analysis for the Flow of Sickle Red Blood Cells in Microvessels for Bio Medical Application

Advanced Bio-sensing Technologies for Sickle Cell Disease Diagnosis

Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation

Morphology-based classification of sickle cell disease and β-thalassemia using a low-cost automated microscope and machine learning

Biophysical Profiling of Red Blood Cells from Thin-film Blood Smears using Deep Learning

A Novel Deep Learning based Model for Erythrocytes Classification and Quantification in Sickle Cell Disease

Deep learning ResNet34 model-assisted diagnosis of sickle cell disease via microcolumn isoelectric focusing

Phenotypic analysis of erythrocytes in sickle cell disease using imaging flow cytometry